These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 5885638)

  • 1. [Salvarsan jaundice].
    Okuda K; Watanabe E
    Naika; 1965 Oct; 16(4):747-51. PubMed ID: 5885638
    [No Abstract]   [Full Text] [Related]  

  • 2. Re-evaluation of the etiology of postarsphenamine jaundice.
    POCOCK DG
    Am J Med Sci; 1954 Jan; 227(1):21-31. PubMed ID: 13114211
    [No Abstract]   [Full Text] [Related]  

  • 3. Fatal post arsphenamine jaundice.
    Chainuvati T
    J Med Assoc Thai; 1974 Mar; 57(3):145-6. PubMed ID: 4463199
    [No Abstract]   [Full Text] [Related]  

  • 4. [Syphilis, salvarsan, jaundice; problem of jaundice in the treatment of syphilis].
    Izv Meditsinskite Inst Bulg Akad Naukite Sofia Otd Biol Meditsinski Nauki; 1951; 2-3():187-210. PubMed ID: 14917481
    [No Abstract]   [Full Text] [Related]  

  • 5. [The mechanism of salvarsan death].
    FAZEKAS IG; DOSA A
    Orv Hetil; 1954 Aug; 95(32):865-70. PubMed ID: 13214798
    [No Abstract]   [Full Text] [Related]  

  • 6. [Salvarsan encephalopathy].
    KLIMENKO AV; ROZMAINSKII IV
    Vestn Venerol Dermatol; 1954; 4():54-5. PubMed ID: 13196275
    [No Abstract]   [Full Text] [Related]  

  • 7. [The mechanism of salvarsan death].
    FAZEKAS IG; DOSA A
    Arch Klin Exp Dermatol; 1954; 198(1):89-102. PubMed ID: 13189396
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the problem of the so-called salvarsan icterus].
    GOTTRON HA
    Dtsch Z Verdau Stoffwechselkr; 1953; 9():77-81. PubMed ID: 13150934
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of salvarsan dermatitis with folic acid].
    FLOTER W
    Z Haut Geschlechtskr; 1954 Aug; 17(3):67-71. PubMed ID: 14374821
    [No Abstract]   [Full Text] [Related]  

  • 10. [Botkin's disease and salvarsan hepatitis].
    ZAKRZHEVSKII EB
    Sov Med; 1954 Apr; 18(4):17-21. PubMed ID: 13187026
    [No Abstract]   [Full Text] [Related]  

  • 11. [Condition of the neuro-vascular system during syphilis in salvarsan complications].
    VASIL'EV TV
    Vestn Venerol Dermatol; 1956; 30(4):25-9. PubMed ID: 13392393
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pathologic and anatomic data in toxic liver dystrophy in early syphilis treated with salvarsan].
    BEZPROZVANNYI BK
    Arkh Patol; 1953; 15(5):45-57. PubMed ID: 13115222
    [No Abstract]   [Full Text] [Related]  

  • 13. [Salvarsan jaundice].
    KRINSKY BK
    Vestn Venerol Dermatol; 1949; 61():8-12. PubMed ID: 18119100
    [No Abstract]   [Full Text] [Related]  

  • 14. [Problem of true salvarsan jaundice].
    ZIERZ P
    Arch Dermatol Syph; 1950; 190(5):456-62. PubMed ID: 14777486
    [No Abstract]   [Full Text] [Related]  

  • 15. [About salvarsan icterus].
    BRUINS SLOT WJ
    Ned Tijdschr Geneeskd; 1948 May; 92(18):1345-8. PubMed ID: 18864543
    [No Abstract]   [Full Text] [Related]  

  • 16. Toxic salvarsan encephalitis.
    Kristanov T
    C R Acad Bulg Sci; 1951; 4(1):17-20. PubMed ID: 13220497
    [No Abstract]   [Full Text] [Related]  

  • 17. Post-arsphenamine jaundice; experience in a military hospital.
    LAFFAN JP
    Ir J Med Sci; 1946 May; ():168-70. PubMed ID: 20982316
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy and prophylaxis of certain side-effects of salvarsan].
    ZINZIUS J
    Hautarzt; 1956 Jul; 7(7):322. PubMed ID: 13366174
    [No Abstract]   [Full Text] [Related]  

  • 19. [The so-called salvarsan-icterus].
    KRINSZKIJ BK
    Borgyogy Venerol Sz; 1949 Dec; 3(12):355-9. PubMed ID: 15402021
    [No Abstract]   [Full Text] [Related]  

  • 20. [Early recognition and prevention of salvarsan agranulocytosis].
    LOISCH ZN
    Munch Med Wochenschr; 1955 Aug; 97(33):1048-51. PubMed ID: 13265669
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.